Folate Receptor Autoantibody Test (FRAT® Test)

Early Detection - Early Intervention - Better Outcome

The early detection of folate receptor autoantibodies is necessary because it can lead to timely diagnosis and appropriate management of conditions associated with these autoantibodies. Folate receptor autoantibodies have been found in Cerebral Folate Deficiency Syndrome, Autism Spectrum Disorders, Schizophrenia, Depression and Neural Tube Defects, among other neurodevelopmental disorders.

The timely initiation of appropriate treatment, such as alternate reduced folates and/or dietary adjustments, may lead to better outcomes and improved overall prognosis for the individual.

As with any medical test, the interpretation of the results and the subsequent treatment plan should be discussed with a qualified healthcare professional.

Science

We continuously research the significance of folate receptor autoantibodies and their implications in various neurodevelopment and neuropsychiatric disorders.

“FRAT^® changed the course of my daughter’s life and our family’s. A simple blood test led our physician on the right path for treatment and today she is thriving! As a parent, you can’t ask for anything more. This would not have happened if we didn’t use FRAT^® to screen for folate receptor autoantibodies. We are forever grateful!”

DEANNA H.

“Having a child with ASD is challenging. Even more challenging is navigating what programs, treatments, therapies, and diets will help them improve; this was overwhelming for us at first. We are so thankful for our knowledgeable doctor and for the FRAT^® test because our child has improved in so many facets – his speech, his socialization, his attention span – it has been remarkable. Thank you, again.”

MAXWELL M.